CD274 and neoplasm: For example, PD-L1-specific CAR-T cells, when used in conjunction with scFv-41BB-CD3-ζ and DC-activated T cells loaded with a CSC antigen, exhibited significant effect in killing cancer cells and reducing the tumor burden in mice, surpassing the effects of any single treatment (185).